This Article Full Text Full Text (PDF) All Versions of this Article: 39/10/2898    most recent STROKEAHA.108.526079v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goldstein, L. B. Search for Related Content PubMed PubMed Citation Articles by Goldstein, L. B. Related Collections Other Ethics and Policy

(Stroke. 2008;39:2898.)
© 2008 American Heart Association, Inc.

Comments, Opinions, and Reviews

Reducing Death and Disability From Stroke

The Role of Governmental Advocacy

From the Department of Medicine (Neurology), Center for Cerebrovascular Disease, Center for Clinical Health Policy Research, Duke University and Durham VA Medical Centers, Durham, NC.

Correspondence to Larry B. Goldstein, MD, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004{at}mc.duke.edu

Governmental actions affect our lives and the lives of our fellow citizens in a variety of ways. This is certainly true for both the conduct of biomedical research and the provision of medical care. Governmental policy-makers require accurate information upon which to base their decisions. Stroke researchers and clinicians are uniquely suited to provide the facts, figures and statistics to help these officials weigh alternative options, and need to become actively involved in the advocacy efforts of their professional organizations. Although written from the perspective of the United States, the issues raised are relevant throughout the world.

Key Words: stroke • public policy • advocacy